Numeric Investors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$12.4M Buy
202,200
+160,400
+384% +$10M 0.09% 213
2017
Q3
$2.66M Buy
41,800
+8,900
+27% +$520K 0.02% 540
2017
Q2
$1.83M Buy
32,900
+4,300
+15% +$234K 0.02% 531
2017
Q1
$1.55M Hold
28,600
0.01% 540
2016
Q4
$1.67M Buy
28,600
+10,600
+59% +$580K 0.02% 536
2016
Q3
$971K Buy
18,000
+13,200
+275% +$848K 0.01% 627
2016
Q2
$353K Sell
4,800
-20,600
-81% -$1.46M ﹤0.01% 839
2016
Q1
$1.62M Buy
+25,400
New +$1.6M 0.02% 468
2015
Q2
Sell
-17,700
Closed -$1.14M 940
2015
Q1
$1.14M Buy
+17,700
New +$1.11M 0.01% 447

Other funds holding BMY

Numeric Investors's BMY Position: Q4 2017 in Review

Numeric Investors increased its Bristol-Myers Squibb (BMY) stake by 384% in Q4 2017, buying an estimated $10M and bringing the position to 202,200 shares worth $12.4M. The position accounts for 0.09% of the portfolio, ranked #213.

Numeric Investors first reported a position in BMY in Q1 2015 and has held it in 9 quarters since. 1,735 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

  • Numeric Investors held 202,200 shares of Bristol-Myers Squibb worth $12.4M as of Q4 2017.
  • Numeric Investors bought 160,400 Bristol-Myers Squibb shares in Q4 2017, an estimated $10M.
  • Bristol-Myers Squibb made up 0.09% of Numeric Investors's portfolio in Q4 2017, its #213 holding.
  • Numeric Investors first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 9 quarters since.
  • 1,735 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.